Perspective Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.45

-0.15 (-3.26%)

As of Mar 22, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target +342.0% upside

Low Target $12.33

Average Target $19.67

High Target $23.14

Current Price $4.45

Current
$4.45

Target
$19.67

$12.33 $19.67 avg $23.14

Scenario Analysis

Bear Case

$12.33

177.1%

Low target

Base Case

$19.67

+342.0%

Avg target

Bull Case

$23.14

+420.0%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$6.16

-27.8% from high

52-Week Low

$1.60

+178.1% from low

Target vs 52W High

$19.67

+219.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%